标题/作者	年份
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak HA Rothan, SN Byrareddy Journal of autoimmunity 109, 102433	2020
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949	2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges CC Lai, TP Shih, WC Ko, HJ Tang, PR Hsueh International journal of antimicrobial agents 55 (3), 105924	2020
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status YR Guo, QD Cao, ZS Hong, YY Tan, SD Chen, HJ Jin, KS Tan, DY Wang, ... Military medical research 7 (1), 1-10	2020
Features, evaluation, and treatment of coronavirus (COVID-19) M Cascella, M Rajnik, A Aleem, SC Dulebohn, R Di Napoli Statpearls [internet]	2022
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses MA Shereen, S Khan, A Kazmi, N Bashir, R Siddique Journal of advanced research 24, 91-98	2020
Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826	2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study T Chen, DI Wu, H Chen, W Yan, D Yang, G Chen, K Ma, D Xu, H Yu, ... bmj 368	2020
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott Jama 324 (8), 782-793	2020
The trinity of COVID-19: immunity, inflammation and intervention MZ Tay, CM Poh, L Rénia, PA MacAry, LFP Ng Nature Reviews Immunology 20 (6), 363-374	2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Y Wang, D Zhang, G Du, R Du, J Zhao, Y Jin, S Fu, L Gao, Z Cheng, Q Lu, ... The lancet 395 (10236), 1569-1578	2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468	2020
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies J Gao, Z Tian, X Yang Bioscience trends	2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) W Alhazzani, MH Møller, YM Arabi, M Loeb, MN Gong, E Fan, ... Intensive care medicine 46 (5), 854-887	2020
In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) X Yao, F Ye, M Zhang, C Cui, B Huang, P Niu, X Liu, L Zhao, E Dong, ... Clinical infectious diseases 71 (15), 732-739	2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell Jama 323 (18), 1824-1836	2020
Compassionate use of remdesivir for patients with severe Covid-19 J Grein, N Ohmagari, D Shin, G Diaz, E Asperges, A Castagna, T Feldt, ... New England Journal of Medicine 382 (24), 2327-2336	2020
The COVID‐19 epidemic TP Velavan, CG Meyer Tropical medicine & international health 25 (3), 278	2020
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ... Nature 582 (7811), 289-293	2020
Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。